Preview

Медицинский Совет

Расширенный поиск

Поражение суставов при ВИЧ-инфекции

https://doi.org/10.21518/2079-701X-2018-9-82-87

Аннотация

В настоящее время ВИЧ-инфекция по-прежнему остается одной из ведущих проблем глобального общественного здравоохранения. Клинические признаки ВИЧ-инфекции крайне разнообразны и ассоциируются со многими, в т. ч. ревматическими, заболеваниями. В настоящем обзоре рассматривается проблема поражения костно-суставной системы при ВИЧинфекции. Представлена подробная клиническая характеристика отдельных нозологических форм (ВИЧ-ассоциированный артрит, реактивный артрит, псориатический артрит и др.), рассмотрены вопросы их дифференциальной диагностики. Проанализированы современные подходы к лечению воспалительных заболеваний суставов при ВИЧ-инфекции, включая генно-инженерные биологические препараты.

Об авторах

Д. В. Буханова
ФБГНУ Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия
Москва


Б. С. Белов
ФБГНУ Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия
Москва


Список литературы

1. Данные на сайте: http://www.who.int/mediacentre/factsheets/fs360/ru.

2. Данные на сайте: www.aids-centr.perm.ru.

3. Duvic M, Johnson TM, Rapini RP et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter’s syndrome. Arch Dermatol, 1987, 123: 1622–32.

4. Berman A, Espinoza LR, Diaz JD, Aguilar JL. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med, 1988, 85(1): 59-64.

5. Yao Q, Frank M, Glynn M, Altman RD. Rheumatic manifestations in HIV-1 infected in-patients and literature review. Clin Exp Rheumatol, 2008, 26(5): 799-806.

6. Fox C, Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol, 2015 Apr, 29(2): 244-58.

7. Chiowchanwisawakit P, Koolvisoot A, Ratanasuwan W, Suwanagool S. Prevalence of rheumatic disease in HIV infected Thai patients. J Med Assoc Thai, 2005, 88(12): 1775-81.

8. Reveille JD. Rheumatic manifestations of human immunodeficiency virus infection. In: Kelley and Firestein’s Textbook of Rheumatology. 10th edition. Eds. GS Firestein, RC Budd, G Sherin, JB Mcinnes, JR O’Dell. Elsevier, Philadelphia. 2017: 1929-1942.

9. Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol, 2003, 17: 265–287.

10. Hochberg MC, Fox R, Nelson KE, Saah A. HIV infection is not associated with Reiter’s syndrome: data from the Johns Hopkins Multi center AIDS Cohort Study. AIDS, 1990, 4(11): 1149-51.

11. Clark MR, Solinger AM, Hochberg MC. Human immunodeficiency virus infection is not associated with Reiter’s syndrome. Data from three large cohort studies. Rheum Dis Clin North Am, 1992, 18(1): 267-276.

12. Monteagudo I, Rivera J, Lopez-Longo J. AIDS and rheumatic manifestations in patients addicted to drugs. An analysis of 106 cases. J Rheumatol, 1991, 18: 1038–41.

13. Marquez J, Restrepo CS, Candia L. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumato, 2004, 31: 741–6.

14. Lawson E, Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection. Br Med Bull, 2012, 103(1): 203-21.

15. Njobvu P, McGill P: Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol, 2005, 32: 1299–1304.

16. Medina F, Jara LJ, Miranda JM, et al. Successful outcome in HIV patients with Reiter’s syndrome treated with bromocriptine. Arthritis Rheum. 1993, 36: 727–8.

17. Calabrese LH, O’Connell M, Kelley DM, et al. A longitudinal study of patients infected with the human immunodeficiency virus (HIV). The influence of rheumatic symptoms on the natural history of retroviral infections. Arthritis Rheum, 1991, 34: 257–63.

18. Reveille JD, Conant MA, Duvic M. Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter’s syndrome: a disease continuum? Arthritis Rheum, 1990 Oct, 33(10): 1574-8.

19. Scott C, Brand A, Natha M. Reactive arthritis responding to antiretroviral therapy in an HIV1-infected individual. Int J STD AIDS, 2012, 23(5): 373-4.

20. Solinger AM, Hess EV. Rheumatic diseases and AIDS – is the association real? J Rheumatol, 1993 Apr, 20(4): 678-83.

21. Buskila D, Gladman D. Musculoskeletal manifestations of infection with human immunodeficiency virus. Rev Infect Dis, 1990 Mar-Apr, 12(2): 223-35.

22. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of im mune reconstitution and changing patterns of disease. Semin Arthritis Rheum, 2005, 35(3): 166-74.

23. Mallon E, Bunker CB. HIV-associated psoriasis. AIDS. Patient Care & Stds, 2000, 14: 239-46.

24. Maurer TA, Zackheim HS, Tuffanelli L, et al. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol, 1994, 31: 372–375.

25. Rieger A, Minsue Chen T, Cockerell CJ. Cutaneous Manifestations of HIV Infection and HIV-related Disorders. In: Dermatology, 3rd ed. Eds. Bolognia JL, Jorizzo JL, Schaffer JV. Elsevier, Amsterdam. 2012: 1285-1302.

26. Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol, 2000, 27(7): 1699-702.

27. Castillo RL, Racaza GZ, Roa FD. Ostraceous and inverse psoriasis with psoriatic arthritis as the presenting features of advanced HIV infection. Singapore Med J, 2014, 55(4): e60-3.

28. Montazeri A, Kanitakis J, Bazex J. Psoriasis and HIV infection. Int J Dermatol, 1996, 35: 475-9.

29. Bartlett BL, Khambaty M, Mendoza N, et al. Dermatological management of human immunodeficiency virus. Skin Therapy Lett, 2007, 12: 1-3.

30. Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features and management. Lancet Infect Dis, 2010, 10: 470–478.

31. Adizie T, Moots RJ, Hodkinson B, et al. Inflammatory arthritis in HIV positive patients: A practical guide. BMC Infect Dis. 2016 , 16: 100.

32. Rosenberg ZS, Norman A, Solomon G. Arthritis associated with HIV infection: radiographic manifestations. Radiology, 1989, 173(1): 171-6.

33. Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: Experience in a tertiary referral center. Indian J Sex Transm Dis, 2013 Jul, 34(2): 107-12.

34. Ouédraogo DD, Ntsiba H, Tiendrébéogo Zabsonré J et al. Clinical spectrum of rheumatologic diseases in a department of rheumatology in Ouagadougou (Burkina Faso). Clin Rheumatol, 2014, 33(3): 385-9.

35. Iordache L, Launay O, Bouchaud O,et al. Autoim mune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev, 2014, 13(8): 850-7.

36. Cunha BM, Mota LM, Pileggi GS,et al. HIV/AIDS and rheumatoid arthritis. Autoimmun Rev, 2015, 14(5): 396-400.

37. Lebrun D, Hentzien M, Cuzin L,et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort. AIDS, 2017, 31(15): 2159-2166.

38. Stein CM, Davis P. Arthritis associated with HIV infection in Zimbabwe. J Rheumatol, 1996, 23(3): 506-11.

39. Azeroual A, Harmouche H, Benjilali L et al. Rheumatoid arthritis associated to HIV infection. Eur J Intern Med, 2008 Oct, 19(6): e34-5.

40. Siva C, Brasington RD. Worsening of arthritis with antiretroviral therapy: the coexistence of rheumatoid arthritis and human immunodeficiency virus infection revisited. J Clin Rheumatol, 2001 Feb, 7(1): 42-6.

41. Ndakotsu MA, Salawu L, Durosinmi MA. Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med, 2009, 18(2): 208-10.

42. Jackson S, Tarkowski A, Collins JE, et al. Occurrence of polymeric IgA rheumatoid factor in the acquired immune deficiency syndrome. J Clin Immunol, 1988, 8: 390–6.

43. Silva AF, Matos AN, Lima AMS, et al. Valor diagnóstico do anticorpo antipeptídeo citrulinado cíclico na artrite reumatóide. Rev Bras Reumatol, 2006, 46: 174–80.

44. du Toit R, Whitelaw D, Taljaard JJ, et al. Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection. J Rheumatol, 2011, 38: 1055–60.

45. Telles JP, Azevedo Grande M, Jurgensen A, et al .Rheumatic manifestations in brazilian patients with AIDS. Acta Reumatol Port, 2014, 39: 143–5.

46. Massabki PS, Accetturi C, Nishie IA, et al. Clinical implications of autoantibodies in HIV infection. AIDS, 1997, 11: 1845-50

47. Allison GT, Bostrom MP, Glesby MJ Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS, 2003, 17: 1–9.

48. Morse CG, Mican JM, Jones EC, Joe G.O., et al. The incidence and natural history of osteonecrosis in HIV–infected adults. Clin Infect Dis, 2007, 44: 739–748.

49. Mehsen-Cêtre N, Cazanave C. Osteoarticular manifestations associated with HIV infection. Joint Bone Spine, 2017, 84(1): 29-33.

50. Belzunegui J, Santisteban M, Gorordo M, et al. Osteoarticular mycobacterial infections in patients with the human immunodeficiency virus. Clin Exp Rheumatol, 2004, 22: 343–345.

51. Louthrenoo W. Rheumatic manifestations of human immunodeficiency virus infection. Curr Opin Rheumatol, 2008, 20: 92–99.

52. Newton L, van Halsema C, Snowden N. HIV and rheumatology: a practical guide. ARUK Topical Reviews, Issue 5, Autumn, 2014.

53. Bourinbaiar AS, Lee-Huang S. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Lett, 1995, 360: 85–88.

54. Njobvu PD, McGill PE. Sulphasalazine in the treatment of HIV related spondyloarthropathy. Br J Rheumatol, 1997, 36: 403–404.

55. Chiang G, Sassaroli M, Louie M, et al. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin Ther, 1996, 18: 1080–1092.

56. Louthrenoo W. Successful treatment of severe Reiter’s syndrome associated with human immunodeficiency virus infection with etretinate: report of 2 cases. J Rheumatol, 1993, 20: 1243–1246.

57. Cepeda EJ, Williams FM, Ishimori ML, et al. The use of anti-tumor necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis, 2008, 67: 710–712.

58. Wangsiricharoen S, Ligon C, Gedmintas L et al. Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune Diseases. Arthritis Care Res, 2017, 69(3): 449-452.

59. Carroll MB, Fields JH, Clerc PG. Rheumatoid arthritis in patients with HIV: management challenges. Open Access Rheumatol, 2016, 8: 51-59.

60. Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood, 2003, 102(8): 2786-8.

61. Paparizos V, Rallis E, Kirsten L, Kyriakis K. Ustekinumab for the treatment of HIV. J Dermatolog Treat, 2012, 23(6): 398-9.

62. Aboulafia DM, Bundow D, Wilske K, Ochs UI. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc, 2000, 75(10): 1093-8.

63. Duvic M, Crane MM, Conant M, et al. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol, 1994, 130: 447–451.

64. Fischer T, Schworer H, Vente C, et al. Clinical impro ve ment of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effec tive antiretroviral therapy. AIDS, 1999, 13: 628–629.

65. Gavegnano C, Detorio M, Montero C et al. Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrob Agents Chemother, 2014, 58(4): 1977-86.


Рецензия

Для цитирования:


Буханова Д.В., Белов Б.С. Поражение суставов при ВИЧ-инфекции. Медицинский Совет. 2018;(9):82-87. https://doi.org/10.21518/2079-701X-2018-9-82-87

For citation:


Bukhanova D.V., Belov B.S. Joint damage in hiv positive patients. Meditsinskiy sovet = Medical Council. 2018;(9):82-87. (In Russ.) https://doi.org/10.21518/2079-701X-2018-9-82-87

Просмотров: 7792


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)